ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1705

Genetic Associations In Anterior Uveitis Implicate T-Cell Co-Stimulation and Other Immune Pathways

Philip Robinson1, Dorith Claushuis2, Paul Leo1, Pamela Mukhopadhyay3, P. Wordsworth4,5, Michael H. Weisman6, Walter P. Maksymowych7, Proton Rahman8, Robert Inman9, Alex Hewitt10, Tammy M. Martin11, James T. Rosenbaum12, Dennis Wakefield13, John D. Reveille14 and Matthew A. Brown15, 1Human Genetics Group, University of Queensland Diamantina Insititute, Brisbane, Australia, 2Human Genetics Group, The University of Queensland Diamantina Institute, Brisbane, Australia, 3Human Genetics Group, The University of Queensland Diamantina Insititute, Brisbane, Australia, 4Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 5Nuffield Orthopaedic Centre, Oxford, United Kingdom, 6Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 7Medicine, University of Alberta, Edmonton, AB, Canada, 8Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 9Immunlogy and Institute of Medical Science, University of Toronto and Toronto Western Hospital, Toronto, ON, Canada, 10Lions Eye Institute, University of Western Australia, Perth, Australia, 11Ophthalmology/L467AD, Oregon Health & Science Univ, Portland, OR, 12Arthritis and Rheumatic diseases, Oregon Health and Science University, Portland, OR, 13Faculty of Medicine, University of New South Wales, Sydney, Australia, 14Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 15University of Queensland Diamantina Institute, Brisbane, Australia

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS) and uveitis

  • Tweet
  • Email
  • Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Anterior uveitis (AU) complicates a number of autoimmune diseases including ankylosing spondylitis (AS), Behcet’s disease and sarcoidosis. It is highly heritable and HLA-B27 is the major risk factor. Functional data has suggested that AU is a T-cell mediated disease. Genes including MHC class II molecules and cytokine genes have been associated with AU. A linkage study has reported suggestive linkage at chromosome 9p21-9p24, but no non-MHC gene has been definitively associated with AU. Our aim was to use an immune focused micro-array to better characterise the genetic variants associated with AU.

Methods:

Cases of AS with AU (n = 1,422), cases of AS without AU (n = 2,339), AU cases alone (n = 289) and healthy controls (HC) (n = 10,000) were recruited. The Illumina Immunochip microarray was used to genotype 190,000 autoimmune related SNPs across the genome selected for their previous identification in autoimmune phenotypes or for fine mapping of association signals already identified. Analysis was completed with the linear mixed model FaST-LMM. We report here the analysis of all AU cases compared to HC. Classical MHC alleles were imputed from genotyping data using the programme HLA*IMP.

Results:

Multiple regions previously reported to be associated with AS were significantly associated. In addition, in this analysis, one rare haplotype (minor allele frequency in controls = 0.0003) spanning the genes CCL19, CCL21 and CCL27 was associated with AU at genome wide significance (P = 2.6 x 10-9, OR = 11.4). Taqman genotyping of the lead SNP in this haplotype was completely concordant with array genotype. Five other loci implicating RGS21 (9.5 x 10-7, OR 1.2), CD28-CTLA4 (9.4 x 10-7, OR = 1.2), POP7 (1.6 x 10-6, OR = 1.3), WFDY4 (7.9 x 10-6, OR = 1.2) and CLECL16A (6.4 x 10-6, OR = 1.3) were associated at a suggestive level of significance (P < 1 x 10-5). HLA-B27 was strongly associated (P = 1 x 10-320, OR = 5.0). Conditioning on HLA-B*27, a protective association with HLA-B*07 was observed (P= 1.2 x 10-6, OR = 0.71).

Conclusion:

Multiple SNPs implicating T cell function and co-stimulation, as well as complement and chemokine pathways were associated with AU. These findings indicate that whilst the genetic risk factors for AS and AU are similar, additional genetic risk variants influence the risk of developing AU that are not involved in AS itself


Disclosure:

P. Robinson,
None;

D. Claushuis,
None;

P. Leo,
None;

P. Mukhopadhyay,
None;

P. Wordsworth,
None;

M. H. Weisman,
None;

W. P. Maksymowych,
None;

P. Rahman,
None;

R. Inman,
None;

A. Hewitt,
None;

T. M. Martin,
None;

J. T. Rosenbaum,
None;

D. Wakefield,
None;

J. D. Reveille,
None;

M. A. Brown,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-associations-in-anterior-uveitis-implicate-t-cell-co-stimulation-and-other-immune-pathways/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology